Note that some links may require registration or subscription.
With an uptick in the number of COVID-19 cases, some experts said it may be time for people at high risk of serious illness or death from COVID-19 to start masking again. (CNN)
The AMA and four other health professional organizations filed an amicus brief urging the U.S. Supreme Court to uphold firearm prohibitions on domestic abusers.
Next week, the Biden Administration is expected to identify the first 10 prescription drugs selected for Medicare price negotiations. (Politico)
Hospital care across England is expected to come to a standstill as senior doctors launch another 48-hour strike. (AP)
AstraZeneca and Vaxess are developing a skin patch mRNA vaccine for pandemic influenza. (Endpoints News)
An international research team assembled the first complete sequence of a human Y chromosome, the final human chromosome to be fully sequenced.
The South Carolina Supreme Court upheld the state law banning abortion after the detection of a fetal heartbeat. (Reuters).
The FDA warned consumers against purchasing — and to immediately stop using — Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops – Eye Repair due to bacterial contamination, fungal contamination, or both.
The agency said certain products marketed as energy supplements are tainted with hidden ingredients that could pose a health risk.
The FDA also announced that EPA veteran James “Jim” Jones will serve as the first deputy commissioner for its proposed unified Human Foods Program.
A gene variant found exclusively among persons of African ancestry may increase the risk of developing Parkinson’s disease. (Lancet Neurology)
Apellis Pharmaceuticals identified an injection needle as the possible cause of severe eye inflammation in patients treated with pegcetacoplan injection (Syfovre).
Twin City Foods is voluntarily recalling a limited quantity of sweet corn and mixed vegetables due to potential Listeria monocytogenes contamination.
E-cigarette maker Juul Labs plans to lay off 30% of its workforce. (Reuters)
Drug maker Mallinckrodt — facing more than $1 billion in opioid settlement payments — filed for bankruptcy a second time. (Washington Post)
CVS Health launched a company to produce and commercialize biosimilar versions of expensive drugs. (Forbes)
Johnson & Johnson’s Janssen Division is closing much of its vaccine research and development operations. (Reuters)
-
Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.
Please enable JavaScript to view the